Some methods of determination of fluoxetine and fluvoxamine;Wybrane metody oznaczania fluoksetyny i fluwoksaminy

Psychiatria Polska

Volumn 36, Issue 4, 2002, Pages 603-616

  Starczewska, Barbara ^a   Mielech, Katarzyna ^a   Kleszczewska, Ewa ^a  

^a UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Fluoxetine; Fluvoxamine; Methods of determination

Indexed keywords

ADOFEN; AVOXIN; BIOXETIN; CITALOPRAM; DOCUTRIX; FLUOXEREN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; NORFLUOXETINE; PAROXETINE; PROZYN; RENEURON; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

CHROMATOGRAPHY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG METABOLISM; DRUG MONITORING; ELECTROCHEMISTRY; HUMAN; QUANTITATIVE ASSAY; REVIEW; SPECTROPHOTOMETRY;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DRUG MONITORING; FLUOXETINE; FLUVOXAMINE; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROTONIN UPTAKE INHIBITORS;

EID: 0036035714     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Pużyński S. Nieselektywne i selektywne inhibitory wchlaniania zwrotnego monoamin w terapil depresji. Post. Psychiatr. Neurol. 1995; 1: 251-268.
2. Pużyński S. Postȩpy farmakoterapii stanów depresyjnych. Lȩk i Depresja 1996; 1 2: 99-120.
3. Pużyński S. Selektywne inhibitory wychwytu serotoniny (SI-5HT) w leczeniu zaburzeń psychicznych, zwtaszcza depresji. Leki Psychotr. 1993; 1: 11-24.
4. Pużyński S. Leki przeciwdepresyjne pierwszej i drugiej generacji. Farm. Pol. 1995; 51: 93-105.
5. Habrat B. Selektywne inhibitory wychwytu serotoniny (SI-5HT) w leczeniu uzależnienia od alkoholu. Leki Psychotr. 1993; 1: 49-57.
6. Bogdanowicz E, Kalinowski A. Objawy niepoża̧dane w czasie stosowania selektywnych inhibitorȯw wychwytu serotoniny (SI-5HT). Leki Psychotr. 1993; 1: 32-40.
7. Bogdanowicz E. Odepresjach. Farm. Pol. 1995; 51: 555-565.
8. Kostowski W. Mechanizmy dziatania leków przeciwdepresyjnych. W: Kostowski W, Pużńyski S, red. Psychofarmakologia Doṡfwiadczalna i Kliniczna. Warszawa: PZWL; 1996; s. 162-180.
9. Bilikiewicz S. Psychiatria Kliniczna. Warszawa: PZWL; 1989:
10. Pużyńiski S, Rybakowski J, Kocur J, Rydzewski Z, Berȩsewicz M., Bogdanowicz E, Duszyk S, Gruszczyṅski W, Kalisznowski A,Koszewska I, Pilaczyńska E, Ṡwiȩcicki L. Ocena kliniczna fluoksetyny (wyniki badaṅ wielooṡrodkowych). Psychiatr. Pol. 1994; 28: 593-600.
11. Pużyński S, Gatuszko P, Strzyżewski W, Berȩsewicz M, Bogdanowicz E, Czerwiński A, Formanowicz J, Kalinowski A, Koszewska I, Landowski J, Nowicki Z, Rajewska J, Ṡwiȩcicki L, Wichowicz H. Fluwoksamina w leczeniu depresji typu endogennego (wyniki badaṅ wielooṡrodkowych w Polsce). Leki Psychotr. 1994; 1: 7-23.
12. Ṡwiȩcicki L. Interakcje selektywnych inhibitorȯw wychwytu serotoniny (SI-5HT). Leki Psychotr. 1993; 2: 41-48.
13. European Pharmacopoeia, London 1997; 867-869.
14. The Merck Index, Twelfth Edition, Merch&Co., Inc., 1996; 709-715.
15. Thomare P. Sensitive micromethod for column liquid chromatographic determination of fluoxetine and norfluoxetine in human. Chromatogr. B. 1999; 583: 217-221.
16. Potts B, Parli C. Analysis of the enantiomers of fluoxetine and norfluoxetine in plasma and tissue using chral derivatization and normal-phase liquid chromatography. J. Liq. Chromatogr. 1992; 15: 665-681.
17. Torok-Both G, Baker G, Coutts R, McKenna K, Aspeslet L. Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J. Chromatogr. 1992; 579: 99-106.
18. Komoroski R. In vivo NMR. Anal. Chem. 1994; 66: 1024A-1033A.
19. Jacobs LS. Farmakologia. Warszawa: Urban&Partner; 1994.
20. Wong S, Dellafera S, Fernandes R. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography. J. Chromatogr. 1990; 499: 601-608.
21. Martindale, Thirty-first Edition by J.E.F. Reynolds, London 1996, 312-316.
22. Podlewski J, Chwalibogowska-Podlewska A. Leki Wspȯlczesnej Terapii. Warszawa: Wydawnictwo Fundacji Büchnera; 1996.
23. Pullen R, Fatmi A. Determination of fluvoxamine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 1992; 574: 101-107.
24. Eap CB, Baumann P. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitirs for therapeutic drug monitoring purposes in patients. J. Chromatogr. B. 1996; 686: 51-63.
25. Fontanille P, Jourdil N, Villier C, Bessard G. Direct analysis of fluoxetine and norfluoxetine in plasma by gas chromatography with nitrogen-phosphorus detection. J. Chromatogr. B. 1997; 692: 337-343.
26. Lantz R, Farid Z, Koons J, Tenbarge B, Bopp R. Determination of fluoxetine and norfluoxetine in human plasma by capillary gas chromatography with electron-capture detection. J. Chromatogr. 1993; 614: 175-179.
27. Clausing P, Rushing L, Newport G, Bowyer J. Determination of D-norfenfluramine and fluoxetine in plasma, brain tissue and brain microdialysate using high-performance liquid chromatography after precolumn derivatization with dansyl chloride. J. Chromatogr. B. 1997; 692: 419-426.
28. Suckow R, Zhang M., Cooper T. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clin. Chem. 1992; 38: 1756-1761.
29. Puopolo P, Flood J. Fluoxetine (Prozac) interference in CN column liquid-chromatographic assays of tricyclic antidepressants and metabolites. Clin. Chem. 1991; 37: 1304-1305.
30. Orsulak J, Kennley T, Debus J, Crowley G, Wittman R. Determination of antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC, with ultraviolet detection. Clin. Chem. 1988; 34: 1875-1878.
31. Parodi B, Caviglioli G, Bachi A, Cafaggi S, Romussi G. Herbal mixtures with claimed slimming activity: Determination by TLC and HPLC of illegally added drugs. Pharmazie 1993; 48: 678-681.
32. Misztal G, Paw B. Determination of fluoxetine hydrochloride in capsules Prozac by HPLC. Acta Polon. Pharm. 1996; 53: 177-179.
33. Misztal G, Skibifiski R. Determination of fluoxetine hydrochloride in capsules and moclobemide in tablets by first, second and third derivative spectrophotometry. Pharmazie 1999; 54: 550-551.
34. Khan I, Aman T, Iqbal M., Kazi A. Spectrophotometric quantitation of fluoxetine hydrochloride using benzoyl peroxide and potassium iodide. Microchim. Acta 2000; 134: 27-31.
35. De Silva A, Lima J, Teles M, Brett A. Electrochemical studies and square wave adsorptive stripping voltammetry of the antidepressant fluoxetine. Talanta 1999; 49: 611-617.
36. Piperaki S, Penn S, Goodall D. Systematic approach to treatment of enantiomeric separations in capillary electrophoresis and liquid chromatography. II A study of the enentiomeric separation of fluoxetine and norfluoxetine. J. Chromatogr. A 1995; 700: 59-67.
37. Piperaki S, Parissi-Poulou M. Evaluation of the chromatographic behaviour of fluoxetine and norfluoxetine using different cyclodextrins as mobile phase additives and fluorimetric detection. J. Liq. Chrom&Rel. Technol. 1996; 19: 1405-1421.
38. Pichini S, Pacifici R, Altieri I, Pellegrini M., Zuccaro P. Stereoselective determination of fluoxetine and norfluoxetine enantiomers in plasma samples by high-performance liquid chromatography. J. Lig. Chrom&Rel. Technol. 1996; 19: 1927-1935.
39. Eap CB, Gaillard N, Powell K, Baumann P. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatographymass spectrometry. J. Chromatogr. B. 1996; 682: 265-272.
40. Atmaca S. Fluorimetric determination of fluoxetine hydrochloride. Pharmazie 1995; 50: 300-301.
41. Van der Meersch-Mougeot V, Diquet B. Sensitive one-step extraction procedure for column liquid chromatographic determination of fluvoxamine in human and rat plasma. J. Chromatogr. 1991; 67: 441-449.
42. Foda H. Quantitative analysis of fluvoxamine maleate in tablet formulations by HPLC. J. Liq. Chromatogr. 1995; 18: 1591-1601.
43. Alhaider A, Hagga M, Alawady M, Gad-Kariem E. Spectrophotometric determination of fluvoxamine in tablets based on charge-transfer complex with chloranil. Anal. Lett. 1993; 26: 887-901.
44. Atmaca S. Spectrophotometric determination of fluvoxamine maleate in tablets. Pharmazie 1994; 49: 458-459.
45. Starczewska B, Mielech K. Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine J. Pharm. Biomedic. Anal. 2000; 23: 243-247.
46. Starczewska B, Puzanowska-Tarasiewicz H, Baranowska K. Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine. J. Pharm. Biomedic. Anal. 2000; 23: 477-481.
47. Nevado J, Salcedo A, Lierena V, Nuevo A. Method development and validation for the simultaneous determination of fluoxetine and fluvoxamine in pharmaceutical preparations by capillary electrophoresis. Anal. Chem. Acta. 2000; 20: 169-176.